Real-time enrollment status for this chronic babesiosis clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 7:10 PM UTC
| NCT Number | NCT06656351 |
| Recruiting Status | Recruiting |
| Condition | Chronic Babesiosis |
| Phase | PHASE2 |
| Target Enrollment | 40 participants |
| Active Locations | 1 sites in the US |
| Sponsor | 60 Degrees Pharmaceuticals LLC |
| Last Updated on CT.gov | November 21, 2025 (Nov 21, 2025) |
As of July 18, 2026: Clinical trial NCT06656351 is currently recruiting participants. This phase2 study for chronic babesiosis is actively seeking new participants at 1 location across the United States. The study is sponsored by 60 Degrees Pharmaceuticals LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06656351 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06656351 was last updated Nov 21, 2025 (November 21, 2025). HelloStudys verifies this status automatically.